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Characterization of a Staphylococcal 
Trimethoprim Resistance Gene 
Abstract 
A thesis submitted in partial fulfillment of the requirements for 
the degree Master of Science at Virginia Commonwealth University. 
by 
Jerald Preston Coughter, B.S. 
Clemson University, 1982 
Director: Gordon L. Archer, Professor 
Departments of Microbiology 
& Immunology and Medicine 
Trimethoprim resistance(Tpr) is encoded by conjugative 
plasmids in clinically significant staphylococcal isolates. Two 
genetically and physically similar plasmids from s. aureus, pG01 
and pGOS, have Tpr genes that map in different locations on 
these plasmids. In order to study the relatedness of the Tpr 
genes and their products to other known Tpr genes, a 1.2 kb 
fragment of pG01 and a 4.2 kb fragment of pGOS were cloned in E. 
coli and used as probes for in situ filter hybridization 
experiments. 
A 500 base pair subclone of the original 1.2 kb fragment 
containing only the staphylococcal Tpr structural gene, showed no 
homology with genes from E. coli encoding a dihydrofolate 
reductase(DHFR) with an altered Tpr binding affinity or the B. 
subtilis gene for DHFR. Positive hybridization signals were seen 
with restriction fragments from pG01, pGOS, and plasmid DNA from 
five other Tpr staphylococci. A 700 bp portion of the original 
fragment showed homology with several different restriction 
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fragments of EcoRI-digested pGOl and pGOS, suggesting the 
presence of repeated sequences on both plasmids. These sequences 
corresponded to areas of the plasmids known to be involoved in 
deletions which occur during viral transductions. 
Lysates of bacteria containing the cloned and native Tpr 
genes were assayed spectrophotometrically for DHFR activity and 
compared with activity of E. coli containing genes for DHFR type 
I and type II. In addition, the Tp Ic50(the concentration of Tp 
required to reduce DHFR activity by 50%) was determined. Tpr 
staphylococci containing the plasmid-encoded Tpr gene had twenty 
times higher specific activity than Tp sensitive staphylococci. 
E. coli containing the cloned staphylococcal gene had DHFR 
activity equal to that of staphylococcal strains from which the 
clones were derived and 300 times higher activity than Tp 
sensitive E. coli. Determination of the Tp Ic50 showed the 
staphylococcal protein to be 7000 times more resistant to Tp than 
the normal cellular DHFR, but four times less resistant to Tp 
than the DHFR type I and 450 times less resistant than DHFR type 
II. The staphylococcal Tpr gene product is a protein with DHFR 
activity that is resistant to Tp inhibition. The gene is 
expressed in E. coli, but is dissimilar to several previously 
characterized E. coli Tpr genes. 
INTRODUCTION 
Numerous studies have shown that resistance to most 
antibiotics occurs by mechanisms involving inactivation, 
detoxification, altered transport, or altered binding of drugs to 
cellular targets. Resistance to inhibitors of dihydrofolate 
reductase(DHFR), such as trimethoprim, arises from a variety of 
mechanisms involving enzyme alteration, cellular impermeability, 
enzyme overproduction, inhibitor modification, and loss of 
binding protein[12]. The mechanism of greatest clinical 
importance is the production of novel, resistant, plasmid-encoded 
DHFRs. 
In 1972, Fleming et al.[16] reported the discovery of R­
plasmids which conferred on Escherichia coli and Klebsiella 
species a high level resistance to trimethoprim. 
R388 was later shown by Aymes and Smith[S] to 
An R-plasmid, 
increase the 
resistance of E. coli to trimethoprim by about 10,000 fold and to 
mediate the synthesis of a DHFR which was about 20,000 times less 
suseptible to inhibition by trimethoprim than the native 
chromosomal enzyme. These kinds of enzymes are now known as type 
I. This mechanism of resistance was of particular interest as 
it was the first example of an R-factor-conferred resistance 
where the cellular target and not the antimicrobial agent was 
modified to manifest the resistant phenotype. Skold and Widh[42] 
further characterized this novel type of DHFR, showing that R­
plasmid R483 produced a type I enzyme that differed from the 
normal, cellular enzyme by being more heat-sensitive and more 
1 
resistant to trimethoprim inhibition. More recently, Aymes and 
smith[6) reported that among its other properties, the DHFR 
mediated by R-plasmid 388 had a molecular weight approximately 
twice that of the sensitive chromosomal DHFR and exhibited an 
insensitivity to methotrexate. Pattishall et al.[34] reported in 
1977 a second type of R-plasmid DHFR, now known as type II. This 
enzyme was completely resistant to methotrexate and trimethoprim, 
yet it retained the ability to bind dihydrofolate tightly. The 
complete nucleotide sequences of the genes encoding DHFR types I 
and II are now known[17, 11]. There is no significant homology 
between them, though the type I sequence shows some homology with 
areas of the E. coli chromosome that encode amino acids 
�---��= 
associated with substrate, cofactor, and inhibitor binding. The 
existence of a third type of plasmid-encoded DHFR in E. coli was 
reported by Fling et al.[18] in 1982. This enzyme differed in 
size, immunologic specificity, and binding characteristics as 
compared to type I and type II. 
Grey et al.[21] studied the mechanism of trimethoprim 
resistance in 36 strains of E. coli and P. mirabilis that did not 
contain R-plasmids. The main mechanism of resistance in the 
majority of E. coli studied was the ·production of altered DHFR 
with a decreased suseptibility to trimethoprim. There was a 
correlation between minimum inhibitory concentration(MIC) of 
trimethoprim and Ic50 of trimethoprim(that is, the concentration 
of the drug required to reduce enzyme activity by 50 percent) for 
the DHFR of these strains. In some cases however, the rc50 was 
2 
in excess of that expected. A suggested explanation for this 
discrepancy was that some strains, in becoming resistant to 
trimethoprim, also became permeable to the drug resulting in a 
disproportionate increase in Ic50 of the DHFR. 
some bacteria have a permeability barrier 
It is known that 
to antifolate 
drugs[47], so that the sensitivity of the isolated enzyme is far 
greater than suggested by the MIC. 
Other strains tested by Grey et al. appeared to have 
different mechanisms of resistance. Among these were strains 
producing an enzyme with a higher specific activity than the 
normal cellular DHFR, some strains with decreased permeability 
for trimethoprim, and possibly some strains that produced a 
second, more resistant form of DHFR. In strains with an increased 
specific activity, it was not clear whether the increase was due 
to more enzyme being produced or an increase in the activity of 
the enzyme due to an alteration in structure. Impermeability has 
been implicated as a mechanism of resistance to trimethoprim in 
strains of Streptococcus faecalis[20] which showed no changes in 
either levels or sensitivity of the DHFR. Jackson and Harrap[26] 
showed in 1973 that only 5% of the normal DHFR activity was 
necessary for the functioning of some mammalian cell lines; the 
same may apply to bacteria. Thus, while a second DHFR was not 
detected, it could have been present in small amounts. The 
presence of a second enzyme more resistant than the normal 
sensitive DHFR was shown in an aminopterin-resistant mutant of 
Streptococcus faecalis[32] as well as in strains containing R-
3 
plasmids[5,42,6,34]. 
Baccanari et al.[7] have shown that sequential passage of� 
coli into increasingly higher concentrations of trimethoprim 
results in the appearance of colonies that grow in the presence 
of >500ug/ml of trimethoprim. These cells show a 500-1000 fold 
increase in DHFR levels. It is doubtful that such strains are 
selected in humans, because such resistance is rapidly lost 
unless the cells are grown in concentrations of trimethoprim that 
would be difficult to reach in vivo. However, despite the 
occasional occurrence in bacteria of other resistance mechanisms 
discussed above, it is clear that trimethoprim-resistant DHFRs 
encoded by R-plasmids are the major cause of trimethoprim 
resistance among clinical isolates[12]. 
Because of their ubiquity and ability to move freely from 
plasmid to plasmid, transposons are thought to have played a 
large role in in the rapid evolutionary spread of bacterial drug 
resistance during the last two decades. A transposon is a 
specific DNA sequence carrying a recognizable genetic 
determinant, such as drug resistance, that moves from one 
replicon to another. Transposition is a nonreciprocal event that 
occurs at the same frequency in the presence or absence of the 
requirements for normal recombination, that is, a functional recA 
gene and regions of extensive homology between the participating 
DNA sequences[27]. Since the original recognition of a 
transposon carrying an ampicillin resistance determinant(Tn!) 
from plasmid RP4[23], many others have been recognized. Barth et 
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al.[9] reported in 1976 the transposition of a DNA sequence 
encoding resistance to trimethoprim and streptomycin from R­
plasmid R483 to other replicons. Originally designated Tnf, this 
transposon is now called Tn7. Barth and Datta[8] went on to show 
that Tn7 exists in nature on E. coli plasmids of different 
incompatibility groups as well as the E. coli chromosome. The 
significance of this finding was demonstrated in 1979 and 1980 
with the emergence of clinical isolates of E. coli with non­
transferable high-level trimethoprim resistance(>1024ug/ml). 
Such high level resistance had previously been associated with 
the presence of a trimethoprim resistance plasmid and it was 
considered possible that the observed resistance was due to a 
plasmid that was incapable of transferring to the standard E. 
coli K12 recipient strain used. However, in 1981, Towner[44] 
showed that in these isolates trimethoprim resistance was encoded 
by a chromosomally-located transposon which could not be 
distinguished from Tn7. Earlier, Shapiro and Sporn[40] found 
that the trimethoprim resistance determinant of plasmid R751 
transposed to bacteriophage lambda. The world wide spread of 
resistance to broad-spectrum penicillins in plasmids of many 
kinds of bacteria of many genera has been attributed, at least 
partly, to the spread of transposon Tn1. It seems, therefore, 
that circumstances are favorable for the spread of resistance to 
trimethoprim, which, like ampicillin, is widely used in 
hospitals. 
Richardson[38] reported in 1983 that while 16% of clinically 
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significant s. epidermidis isolates from England were highly 
trimethoprim resistant(MIC >500ug/ml), only 4% of 
epidemiologically independent isolates from northern Europe and 
North America were trimethoprim resistant. The latter figure is 
in contrast to the 17% trimethoprim resistance frequency reported 
in American s. epidermidis isolates by Archer et al. in 1986[1]. 
Archer et al. also reported a higher frequency of resistance 
among s. aureus(10%) isolates than was earlier reported[3]. 
Thus, high-level trimethoprim resistance among both S. 
epidermidis and s. aureus seems to be increasing in this country. 
Conjugative transfer of aminoglycoside resistance plasmids 
among staphylococci was first reported in 1983 by Forbes and 
Schaberg[19] and independently confirmed by McDonnell et al.[31]. 
Archer and Johnston[2] identified a group of related self­
transmissible plasmids found in both s. epidermidis and s. aureus 
isolates 
exhibited 
that encoded resistance to aminoglycosides. 
five different restriction endonuclease 
This group 
digestion 
patterns. Archer et al.[1] also showed that a methicillin­
resistant s. aureus isolate resistant to trimethoprim transfered 
that resistance serially by filter mating to suitable S. aureus 
and s. epidermidis recipients. 
beta-lactamase production were 
Resistance to gentamicin and 
cotransferred. 
resistance determinants 
All three 
were encoded on a single 55 kilobase 
plasmid(pG05)(Figure 
gentamicin-resistant 
clinical isolates of 
1). A similar trimethoprim-resistant, 
conjugative plasmid was also found in 
methicillin-suseptible s. aureus and 
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methicillin-resistant s. epidermidis. In situ filter 
hybridization showed that there was homology between a cloned 4.2 
kilobase EcoRI fragment of pGOS containing the trimethoprim 
resistance determinant and other plasmid-associated trimethoprim 
resistance genes from staphylococci, but not with gram-negative 
plasmid-encoded trimethoprim resistance genes. Plasmid-mediated 
trimethoprim resistance has not been previously reported among 
staphylococcal isolates from the United States. While such 
resistance has recently been reported among methicillin-resistant 
s. aureus isolates from Australia[45], the nature of this 
determinant has not been characterized in any detail. Plasmid-
mediated trimethoprim resistance has not been reported previously 
in coagulase-negative staphylococci. 
This thesis is a report of the first characterization of the 
staphylococcal trimethoprim resistance gene and its protein 
product. The gene was mapped using restriction endonuclease 
analysis. The gene was cloned in E. coli and its relatedness to 
other 
gene 
known 
known trimethoprim resistance genes was determined. The 
product was analyzed biochemically and compared to other 
trimethoprim resistance gene products. These data were 
used to determine the mechanism of resistance. The results of in 
situ filter hybridization experiments have suggested that a 
repeated sequence of DNA may mediate both intermolecular and 
intramolecular rearrangements that might account for the presence 
of the trimethoprim resistance determinant in different locations 
on otherwise similar replicons. This is the first report of 
possible insertion sequence-like elements in staphylococci. 
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MATERIALS AND METHODS 
A. Chemicals, Media, and Antibiotics 
Restriction enzymes and reaction buffers were purchased from 
International Biotechnologies, Incorporated(IBI, New Haven, CT). 
T4-DNA ligase and DNA nick translation kits were bought from New 
England Nuclear(NEN, Boston, MA). Agarose and acrylamide were 
obtained from IBI. Technical grade cesium chloride was bought 
from Kawecki, Berlyce Industries, Incorporated(KBI, Reading, PA). 
Trimethoprim, ampicillin, tetracycline, RNase, and various 
compounds such as boric acid, lysozyme, lysostaphin, calcium 
chloride, tris, folic acid, NADPH, and ethidium bromide were 
purchased from Sigma Chemical Company(Sigma, St. Louis, MO). 
Mueller-Hinton agar and broth were from BBL Microbiology 
Systems(BBL, Cockeysville, MD). Antibiotic media #5 and brain 
heart infusion broth were obtained from Difco Laboratories(Difco, 
Detroit, MI). L-broth was from Gibco Laboratories(Gibco, 
Madison, WI). Solvents such as chloroform and hydrochloric acid 
were purchased from J. T. Baker Chemical Company(Phillipsburg, 
NJ). Phenol was obtained through Scientific Products(S/P, McGaw 
Park, IL). 
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B. 
strain/phenotype 
E. coli 
SK1592/hsdR4 Gal 
q + -01204/laci o z 
P17 
P113 
P1242 
S. aureus 
RN450 
RN4220 
G1 
GS 
WG525 
Bacterial Strains 
plasmid/phenotype 
r 
pFE506/Tmp 
pFE364/Tmpr 
pFE1242/Tmpr 
pG01/Tmpr 
pGOS/Tmpr 
pWG53/Tmpr 
remarks/reference 
restriction deficient, 
transformation recipient 
(Kushner[28]) 
lac repressed host strain 
for plasmid pOP203(A 2 +) (Winter and Gold[46]T 
colE1::Tn7, DHFR type 1 
(Fling[17]) 
DHFR type 2 
(Fling [ 17] ) 
DHFR type 3 
(Fling[18]) 
s. aureus 8325-4 
(Novick[33]) 
RN450 derivative, 
restriction deficient 
(Novick[33]) 
wild isolate, Virginia 
(Archer[!]) 
9 
wild isolate, Pennsylvania 
(Archer[!]) 
wild isolate, Australia 
(Grubb[45]) 
c. 
10 
Stock Solutions 
E. coli mini-lysate buffer 
DHFR assay buffer 
gel denaturant 
gel neutralizer 
sse 
SOX Denhardt's Reagent 
SSPE 
Prehybridization Solution 
Hybridization Solution 
Probe Denaturant 
TE Buffer 
TES buffer 
TBE buffer 
SDS 
Brij 
Tracking Dye 
ethidium bromide solution 
low salt buffer 
50mM tris, 15% sucrose, 50mM EDTA 
50mM tris, pH7.5, 150mM KCl, 
1mM EDTA, 10mM mercaptoethanol 
1.5M NaCl, 0.5M NaOH 
3M NaCl, 0.5M tris, pH7 
1X = 0.15M NaCl, 0.015M NaCitrate 
0.02% ficoll, 0.02% BSA, 
0.02% polyvinylpyrollidone 
0.18M NaCl, 10mM NaP04, 
1mM EDTA, pH7 
5X Denhardt's Reagent, 5X SSPE, 
200ul denatured salmon 
sperm DNA, 50% formamide 
1X Denhardt's Reagent, 1X SSPE, 
200ul denatured salmon 
sperm DNA, 50% formamide 
50% formamide, 10mM tris, pH7, 
0.1mM EDTA 
50mM tris, 5mM EDTA, pH8 
50mM tris, 5mM EDTA, 500mM NaCl, 
0.089M tris-borate, 0.089M Boric 
acid, 0.002M EDTA 
sodi.um dodecyl sulfate in TE 
5% Brij 58, 1% deoxycholate, 
0.05M EDTA, 0.05M tris, pH8 
0.07% bromophenol-blue, 
7% SDS, 33% glycerol 
ethidium bromide 10mg/ml in TBE 
0.1M NaCl, 0.05M EDTA, pH6.9 
pH8 
D. Isolation of Plasmid DNA from E. coli 
When a colony displayed a desired phenotype, it was lysed by 
a "mini-lysate" procedure[14] to examine its plasmid DNA. In this 
procedure, an overnight culture of the colony was lysed by the 
addition of lysozyme, SDS, and KAc. To remove any cellular RNA, 
RNAse was added. Soluble proteins were extracted by treatment 
with phenol resulting in an aqueous layer which contained the 
plasmid DNA. This DNA was used for restriction digestion and 
electrophoresis as described below(section F). 
E. Purification of Plasmid DNA by Equilibrium 
Centrifugation in Cesium Chloride-Ethidium Bromide Gradients 
If the minilysate procedure indicated that the E. coli cells 
lysed contained a desired DNA construct, cultures of the 
corresponding colony were lysed and the procedure of Clewell and 
Helinski[43] was followed to obtain plasmid DNA. Isolation of 
staphylococcal plasmid DNA was by a procedure reported by Archer 
et al.[4], in which lysostaphin is used to prepare osmotically 
fragile cell forms. In each case the resulting DNA solution 
contained covalently closed, circular �lasmid DNA as well as some 
broken, linear molecules of chromosomal DNA which were too small 
to be separated with the other cellular debris. Plasmid DNA 
was further purified by the procedure of Radloff et al.[37]. In 
this procedure, the DNA solutions from above were mixed with 
solutions of cesium chloride and ethidium bromide, and the 
mixture was centrifuged for 48 hours at 40,000 RPM in a Sorvall 
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70Ti rotor at room temperature. Because the two bacteria 
have different GC content, the concentration of cesium chloride 
used was different for E. coli and staphylococcal plasmid DNA 
purifications(for E. coli, 8 g of CsCl/7.7 ml of DNA solution; 
for staphlococci, 5.9 g CsCl/6.4 ml DNA solution ). Following 
ultracentrifugation, the presence of ethidium bromide allowed the 
visualization of a plasmid DNA band using an ultraviolet light. 
A fraction containing the band was collected and treated with 
isopropanol to extract the ethidium from the DNA. The solution 
was the dialysed overnight to remove the cesium chloride. 
F. Restriction Endonuclease Digestion and Ligation Reactions 
Restriction endonuclease digestion of DNA was performed 
according to the manufacturer's specifications. Reactions were 
generally carried out in a total volume of 15ul(l2.5ul DNA, 1.5ul 
lOX reaction buffer, lul restriction enzyme). Tubes were placed 
in a 37°c multiblock heater and digestion allowed to proceed for 
90 minutes. Reactions were stopped by the addition of tracking 
dye if the DNA was to be electrophoresed or by ethanol 
precipitation and phenol extraction if the DNA was to be used in 
a ligation. DNA ligations were performed 
usually in a total volume of 25ul(21.5ul DNA, 
using T4-ligase, 
2.5ul lOX ligation 
buffer, lul ligase). 
for one hour at 25°. 
Incubation was either overnight at 4°C or 
12 
G. Transformation of Competent Cells 
A suitable recipient strain(SK1592) of E. coli 
�--��= 
was 
transformed, according to the method of Davis[15], with purified 
plasmid DNA. Transformed cells were selected phenotypically by 
plating on media containing antibiotics. Selective media was 
prepared by adding one or more antimicrobial agents(trimethoprim 
@ 25ug/ml, tetracycline @ 10ug/ml, ampicillin @ 20ug/ml) to 
Mueller-Hinton agar before casting into petri plates. 
H. Agarose Gel Electrophoresis 
DNA solutions were electrophoresed through 0.7 or 0.9% 
agarose in TBE buffer according to a method adapted from 
Maniatis[30]. Gels were run in TBE buffer either vertically(14cm 
x 5.0 x 0.2cm) or horizontally(7.5cm x S.Ocm x 0.2cm). 
Electrophoresis was performed by applying a current of 100 volts. 
When the dye front reached the end of the gel(approximately 120 
minutes for vertical, 90 minutes for horizontal), gels were 
removed and stained for ten minutes with an ethidium bromide 
solution. Gels were destained for five minutes under cold, 
running tap water and placed on an ultraviolet 
transilluminator(UVP Inc., San Gabriel,
" 
CA) to visualize the DNA. 
Photographs of gels were taken with a Polaroid camera(S/P). DNA 
size markers were purchased from BRL and the size of DNA 
restriction fragments was determined relative to those markers by 
linear regression analysis. 
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I. Polyacrylamide Gel Electrophoresis 
Polyacrylamide gels[30] were run in the same vertical 
apparatus as agarose gels. Polyacrylamide was prepared by mixing 
4g acrylamide, 0.13g bis-acrylamide, 40mg ammonium-persulfate, 
and 80ml TBE buffer in a 250ml erlenmeyer flask. Immediately 
before pouring the gel, 80ul TEMED(N,N,N' ,N' ,-tetramethylethylene 
diamine) was added to begin the polymerization reaction. The gel 
was allowed to polymerize for one hour before the addition of 
DNA. A current of 150 volts was applied to drive the DNA through 
the polyacrylamide. When the dye front reached the end of the 
gel(approximately one hour), the gel was removed, stained with an 
ethidium bromide solution for 20-30 minutes, and destained under 
cold, running tap water for 20-30 minutes. DNA was visualized 
and photographs taken in the same manner as described for agarose 
gels. 
J. In situ Filter Hybridization 
To assess DNA-DNA homology, in situ 
hybridization("Southern blotting") was performed by the 
of Southern[38]. Following agarose gel electrophoresis, 
filter 
method 
the gel 
was stained and photographed as usual.- The gel was exposed to 
ultraviolet light for 2-5 minutes in order to introduce single 
strand breaks into the DNA. DNA was denatured by soaking the 
gel in gel denaturant. This was followed by soaking in gel 
neutralizer. 
Nitrocellulose paper(Schleicher and Schuell, Keene, NH) was 
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prepared as described by Maniatis[30]. Gloves were worn 
throughout the procedure. The filter was placed on top of the 
gel in such a manner that the DNA would transfer from the gel to 
the nitrocellulose as 20X sse passed through the gel and the 
filter paper. Following incubation overnight, the gel was peeled 
off the nitrocellulose and restained with ethidium bromide to 
determine the efficiency of transfer. The filter was placed 
between two sheets of 3MM paper, clamped between two pieces of 
glass, and dried under a vacuum at 80°C for two hours. After 
drying, the filter was stored in a vacuum dessicator at room 
temperature. 
In order to determine if there was homology between the DNA 
which was blotted to the nitrocellulose paper(target) and the 
cloned staphylococcal plasmid DNA in question(probe), DNA was 
radiolabelled with 32P by in vitro nick translation. Nick 
translation was performed according to the instructions provided 
in the NEN nick translation kit. The stringency of hybridization 
between the probe and the target is determined by the ionic 
strength of the solutions and the Tm, that is, the temperature at 
which a DNA duplex is 50% denatured. The Tm for a given 
experiment is dependent upon the concentration of formamide used 
and the G + C ratio of the DNA. Each increase of 1% in the 
formamide concentration lowers the Tm of a DNA duplex by 
0 0.7 C[30]. For 80% stringency, the filter was prehybridized at 
42°C for one hour in prehybridization solution(SO% formamide), 
15 
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the correct volume of which is determined as 100ul/cm2 of filter. 
During this incubation, the probe was denatured by the addition 
of 300ul of formamide and 200ul of probe denaturant and heating 
at 65°C for five minutes. The filter was then soaked overnight 
at 42°c in hybridization solution plus the probe. After 
incubation overnight, the filter was twice washed for 15 minutes 
in a solution of 2X SSPE and 0.1% SDS, and twice in a solution of 
0.1X SSPE and 0.1% SDS. After the filter was allowed to air dry 
at room temperature, it was placed in a Dupont X-Ray 
cassette(S/P) with a piece of Kodak X-Ray film and exposed 24-
72 hours at -70°c. 
K. Gene Product Analysis 
DHFR was isolated as described by Sheldon and Brenner[41]. 
overnight cultures were harvested by centrifugation and lysed in 
DHFR assay buffer. 
5mg/ml lysostaphin. 
Staphylococci were lysed by treatment with 
E. coli strains were lysed by sonication 
with a microprobe on a Fisher sonicator. DHFR is labile to 
prolonged sonication and care was taken to use short bursts of 
sonication while keeping the cells on ice. 
DHFR activity was measured using a Beckman Model 25 
spectrophotometer by the method described by Poe et al.[36] 
involving the decrease in absorbance that occurs at 340nm when 
NADPH and dihydrofolate(FH2) are reacted to form NADP
+ and 
tetrahydrofolate(FH4), respectively. 
method of Blakely[10]. Assays were 
was prepared by 
performed at 
the 
room 
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temperature. Standard conditions included, in addition to assay 
buffer, lOOuM NADPH, and O.OlmM FH2, and an appropriate amount of 
cell extract to achieve a final volume of 1.16ml. Baseline 
values for all strains were determined by measuring the 
absorbance before the addition of FH2. After each strain was 
examined for DHFR activity, assays were repeated with the 
addition of increasing amounts of trimethoprim(l0-
7 
to 10-2M) to 
determine the rc50(the concentration of trimethoprim at which 50% 
of DHFR activity was inhibited). 
L. Disk-plate Bioassay for Trimethoprim 
To determine if trimethoprim was being altered or destroyed 
by bacterial cultures a disk-plate bioassay was performed[29]. 
Absorbant paper disks were inoculated with broth cultures of 
trimethoprim resistant or trimethoprim sensitive bacteria. The 
disks were placed on a surface of agar containing a dispersion of 
indicator organism. Antibiotic diffused from the disk and 
inhibited growth of the organism. After a suitable incubation 
period, the zone of inhibition around each disk was measured. 
The sizes of the inhibition zones produced by known 
concentrations of antibiotic were plotted against the 
concentrations to form a standard curve. Zones of inhibition 
were measured using a Fisher-Lilly antibiotic zone reader(Fisher) 
and the concentration of trimethoprim in the sample was 
determined from the standard curve. This value was compared to 
the known concentration of trimethoprim in the sample prior to 
incubation to determine if the trimethoprim was destroyed. 
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RESULTS 
Two trimethoprim resistance plasmids, pG01(figure 1) and 
pGOS(figure 2), were shown by restriction endonuclease mapping to 
be genetically similar. pG01 is from a clinically significant 
methicillin-susceptible s. aureus isolated at the Medical College 
of Virgina's newborn intensive care unit, while pGOS is from an 
epidemic methicillin-resistant s. aureus isolated at the 
Philadelphia Veterans Hospital. Resistance markers(gentamicin, 
quarternary ammonium-ethidium bromide, and trimethoprim) are in 
different locations, relative to each other, on these plasmids. 
A c E F B D G H 
I I I I I I I I I 
0 ********************* *******50Kb :--f <--'--' ----------
�p Gm
rQamt Tra 
Figure 1. EcoRI restriction digest map of pG01. I indicates 
restriction site, capital letters indicating descending order of 
migration in agarose gels, **** indicates area known to delete 
during transduction experiments. 
Previously, EcoRI digests of pGOS and a deletion derivative 
of pG01 in which the 15 Kb EcoRI A fragment was reduced to 8.7 Kb 
(pG01-5A) were cloned into + pOP203(A2 ), transformed into 
restriction deficient E. coli recipient SK1592[28], and selected 
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on nutrient agar containing trimethoprim and tetracycline. 
Engineered by Winter and Gold[46], pOP203(A2
+) is a vector that 
allows for positive selection of clones because it contains the 
A2 gene of Q-beta phage. The A2 gene encodes a protein that 
kills the cell unless the gene is interrupted by inserted(cloned) 
DNA. All trimethoprim-resistant E. coli transformants contained 
either the 4.2 Kb EcoRI F fragment of pG05 or the 8.7 Kb EcoRI A 
fragment from pG01-5A and were resistant to trimethoprim to the 
same degree as were the staphylococci from which the genes were 
obtained(MIC >lOOOug/ml). 
A E G F c B D H 
I I I I I I I I I 
0 55 
<-1 ___ 1 
- ------- :--f l ____ l 
GmtQamt 
I I 
Tra �p Bla 
Figure 2. EcoRI restriction digest map of pG05. I indicates 
restriction site, capital letters indicate descending order of 
migration on agarose gels. 
It was noted that some clones containing the appropriate 
fragments did not express trimethoprim resistance. Restriction 
endonuclease mapping revealed that in these clones the fragments 
were inserted in the opposite orientation of those expressing 
resistance. Because the A2 gene in the cloning vector is under 
the control of the lac promotor/operator, it was possible that 
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the cloned fragment did not include the normal staphylococcal 
promotor and that expression of trimethoprim resistance was under 
control of the lac promotor/operator. To investigate this 
possibility, pG012, the clone containing the 4.2 Kb fragment from 
pGOS, was transformed into Dl204, an E. coli strain containing an 
iq mutation on an Flac plasmid so that it hyperproduces lac 
repressor[46]. Trimethoprim resistance was expressed at the same 
high level in these transformants as it was in SK1592 in which 
the promotor was fully induced. This result suggested the cloned 
fragments included their own staphylococcal promotor for the 
trimethoprim resistance gene and that this promotor was 
functional in E. coli hosts. The conclusion that the clone 
included the staphylococcal promotor was further supported when 
the 4.2 Kb fragment from pGOS was subcloned onto the E. coli 
vector pBR322(designated pG016) and full expression of 
trimethoprim resistance was retained. 
Restriction endonuclease mapping of pGOll, the 8.7 Kb 
fragment cloned + on pOP203(A2 ), revealed the existence of a 
Bglii restriction site 1.2 Kb from the end of the EcoRI fragment. 
This site was exploited in defining the limits of the 
trimethoprim resistance gene because the vector contained a 
single Bglii site downstream of the promotor. Following 
digestion with Bglii and religation, the remaining 1.2Kb EcoRI­
Bglii fragment of pGOl-SA was found to be sufficient to encode 
trimethoprim resistance. This clone, pGOlS(Figure 3), was 
analysed for restriction sites in order to better define the 
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structural limits of the gene and to obtain probes for in situ 
filter hybridization studies. In addition, pGOlS was also 
transformed into D1204, the strain hyperproducing lac repressor. 
These transformants retained full expression of trimethoprim 
resistance, suggesting that this clone(pGOlS) also included the 
staphylococcal promotor. 
Cells containing the pGOlS clone exhibited MIC values 
similar to those of the native staphylococcal strain. Neither 
Bglii EcoRV 
I 200bp -; SOObp 
Hindi II 
I SOObp 
EcoRI 
-1 
<--------------------------***** 
Tmpr 
I GOlS 
I pG020 I 
I pG018 
Figure 3. Structural Map of Trimethoprim Resistance Gene 
showing approximate distances between restriction 
sites(/). The precise locations of the 5' and 3' 
termini of the gene are not known. 
I 
I 
the SOObp EcoRI-Hindiii nor the 700bp Hindiii-Bglii fragment 
-- --
mediated trimethoprim resistance when subcloned on pBR322(pG018 
and pG020, respectively) indicating that the single Hindi!! site 
fell within the structural gene. A 2.2 Kb Bglii-EcoRV fragment 
of pGOl subloned on pBR322 encoded trimethoprim resistance, 
indicating that the EcoRV site was outside the gene. 
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The entire trimethoprim resistance structural gene was 
contained in pGOlS while only portions of it were carried by 
pG018 and pG020. These three clones were employed as probes 
for in situ filter hybridization studies to determine the 
relatedness of the gene to other known trimethoprim resistance 
genes. Table 1 summarizes the results of these 
experiments. No homology was seen between any of the probes 
and the =E�.--�c�o=l=i DHFR genes. pGOlS did show homology with 
chromosomal DNA from some resistant staphylococcal strains and 
plasmid DNA from both resistant and sensitive strains. Homology 
was also seen with a resistance plasmid from an Australian, 
methicillin-resistant isolate. No homology was seen with the 
cloned genes from B. subtillis encoding DHFR and thymidine 
kinase. 
pG018 showed homology only with plasmid DNA that encoded 
trimethoprim resistance and with chromosomal DNA from resistant 
strains. When the target DNA was digested with restriction enzyme 
EcoRI, hybridization was seen only with fragments known to 
include the trimethoprim resistance determinant. 
pG020 showed homology with plasmid DNA that encoded 
trimethoprim resistance and with trimethoprim-sensitive plasmids 
similar to pGOl and pGOS. When pGOl target DNA was digested with 
restriction enzyme EcoRI, hybridization of the pG020 probe was 
exhibited with multiple fragments. Figure 4 shows a linearized 
EcoRI restriction map of pGOl indicating areas that gave 
22 
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Table 1. Summary of results of in situ 
filter hybridization experiments 
Target DNA 32 P-labeled :12robe 
Elasmid sus:�t.a EG015 EG018 EG020 
pG015 r + + + 
pG018 s + + 
pG020 s + + 
pG016 r + + + 
pGOl r + + + 
pGOS r + + + 
pG02 s + + 
pG03 s + + 
pG04 s + + 
pG07 s + + 
pG071b s + + 
pG072b s + + 
pG073b s + + 
pG074b s + + 
pG075b s + + 
s. eEi. 
chromosome r + + + 
Co1El::Tn7 r 
pFE364 r 
pWG53 r + nd nd 
pERl s nd nd 
a. resistant(r) - growth in broth culture with 20 ug/ml Tmp 
sensitive(s) = no growth in bfothsculture with <10
 ug/ml Tmp 
b. Conjugative plasmids from Gm Tmp isolates 
positive hybridization signals with pG020 and areas where 
deletions sometimes occured during transduction experiments. It 
can be seen that these areas overlap. Another area that showed 
homology with pG020 is the area to which the insertion site of a 
beta-lactamase transposon has been localized. Such homology was 
seen also between pG020 and trimethoprim-sensitive plasmids 
similar to pGOl and pGOS. 
H A 
TMPr-> 
c E F B D G 
I I*** *** I I I ***I *****I I*** I 
I I I I 
I I I I 
I I I I I 
I I I I I 
<-- --> <-- I --> I 
SB SA SA I SB I 
I 
I 
beta-lactamase 
Transposon 
insertion site 
Figure 4. Linearized restriction map of pGOl. 
key: ***** 
= areas which show homology with pG020. 
i = sites where deletions occur during 
i transductions. 
I = EcoRI restriction sites 
Capital letters indicate descending order of 
migration of EcoRI fragments in agarose gels 
Two possible mechanisms of resistance were investigated. 
First, an assay was designed to measure whether or not 
trimethoprim is destroyed or altered by resistant bacteria. As a 
negative control, one sample contained a solution of trimethoprim 
and no bacteria. An organism known to destroy trimethoprim was 
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not available for use as a positive control, however SK1592 
transformed with pFE364(encoding DHFR type II) is known to be 
extremely resistant to trimethoprim[17]. The strains of 
interest in this assay were a wild staphylococcal isolate 
containing the whole pGOl plasmid(661) and SK1592 transformed 
with pGOlS, the cloned trimethoprim resistance gene from pGOl. 
Measurements of the amount of trimethoprim remaining in the 
cultures after incubation periods showed no evidence of 
destruction of the drug(Table 2). 
Table 2. Disk-Plate Bioassay for Trimethoprim Destruction 
Strain TrimethoErim in Culture(ug/ml) 
Ohr 1hr 2hr 3hr 4hr Shr 6hr 24hr 
none 3.3 4.2 3.7 3.3 2.7 3.0 2.9 2.9 
661 3.1 2.8 3.1 3.1 3.6 2.3 3.1 a 
SK1592/pG015 4.2 4.3 3.4 3.1 3.4 3.0 3.1 2.9 
SK1592/pFE364 3.9 4.2 3.9 6.9 3.8 2.9 2.9 2.0 
a. culture died 
Second, an assay was developed to determine if the 
trimethoprim resistance gene product had any DHFR-like activity, 
the mechanism described for plasmid-mediated trimethoprim 
resistance in E. coli. The data is summarized in Table 3. Five 
E. coli strains and four s. aureus strains were assayed. 
Negative controls were a transformant of SK1592 containing 
pBR322, and two staphlococcal strains, RN450 and RN4220. 
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Positive controls were transformants of SK1592 containing 
Co1El::Tn7 encoding E. coli DHFR type I and pFE364 encoding DHFR 
type II. The clones assayed were transformants of SK1592 
containing pG016(the trimethoprim resistance gene from pGOS 
cloned on pBR322) and pG015 (the trimethoprim resistance gene 
from pGOl cloned on + pOP203(A2 )). Also assayed was RN450 
transformed with pGOl-SA, the trimethoprim-resistant deletion 
derivative of pGOl, and RN4220 transformed with pGOS. 
Trimethoprim resistant staphylococci expressed a protein with a 
DHFR activity twenty times greater than that of trimethoprim 
sensitive staphylococci. 
determinant exhibited 
E. coli clones of the staphylococcal 
specific activities equal to the 
staphylococcal isolates and 300 times greater than trimethoprim 
sensitive E. coli. The specific activities of the 
staphylococcal protein expressed in E. coli clones were not 
significantly different from those of E. coli DHFR type I and 
type II. The similarities in specific activity demonstrated by 
these trans formants indicated that the staphylococcal 
trimethoprim resistance gene product was a DHFR-like protein. 
The high levels obtained for MIC's showed the resistance was 
equally well expressed in E. coli as in the staphylococcal 
strains. However, the staphyloccal gene product was four times 
less resistant than E. coli DHFR type I and 450 times less 
resistant than type II. These results suggested the proteins 
were dissimilar. 
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a. 
b. 
c. 
Table 3. Characterization of DHFR produced by 
transformed E. coli and s. aureus strains 
Strain(plasmid) 
SK1592(pBR322) 
SK1592(pG016) 
SK1592(pG015) 
SK1592(ColE1::Tn7) 
SK1592(pFE364) 
RN450 
RN450(pG01-5A) 
RN4220 
RN4220(pG05) 
Spec. 
DHFR 
Act. a 
0.2 
5.8 
18 
7.1 
5.3 
1.2 
21 
4.8 
14 
ICSO 
b 
0.01 
7.7 
5.6 
29 
3600 
0.01 
6.9 
0.01 
1.0 
MICe 
2.5 
>1000 
>1000 
>1000 
>1000 
10 
>1000 
10 
>1000 
specific activity is measured as nM of folate reduced/min/mg 
total cellular protein. 
IC is the uM concentration of trimethoprim required to 
redace DHFR activity by 50%. 
MIC is the minimum amount of trimethoprim (expressed in ug/ml) 
neccesary to inhibit growth in a broth culture. 
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DISCUSSION 
Trimethoprim resistant staphylococci express a DHFR-like 
protein with a specific activity twenty times greater than that 
of trimethoprim sensitive isolates. The trimethoprim resistance 
determinant is encoded on large conjugative plasmids and in the 
chromosomes of some isolates. The plasmid-encoded determinant 
has been cloned in E. coli on a 1.2 kilobase DNA fragment 
inserted into the + vector pOP203(A2 ) and on a 4.2 kilobase 
fragment inserted into the vector pBR322. These clones 
expressed trimethoprim resistance in E. coli at levels as high as 
those seen in staphylococci and equal to that of the previously 
characterized E. coli DHFR genes. These genes are expressed 
equally well on low copy number plasmids in staphylococci and 
high copy number vectors in E. coli. Trimethoprim resistance can 
be used, therefore, as a marker on shuttle plasmids. 
Restriction endonuclease mapping of the E. coli clones of 
staphylococcal DNA has shown the gene to be encoded on a one 
kilobase EcoRI-EcoRV fragment. A Hindiii site located 500 base 
pairs from the EcoRI site has been shown to inactivate the gene. 
No other sites for common restriction endonucleases have been 
found within the gene. 
Gene expression in one orientation and not the other may 
suggest the direction of transcription. When transcription is in 
the same direction as that of the lac promotor or when the lac 
promotor is turned off, trimethoprim resistance is expressed. 
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When the direction of transcription of the staphylococcal 
promotor is in opposition to that of the lac promotor, 
trimethoprim resistance is not expressed, perhaps because the 
staphylococcal promotor has a lower affinity for E. coli RNA 
polymerase than the E. coli lac promotor. 
Enzyme assays have shown that the gene product of the 
trimethoprim resistance determinant is a DHFR-like protein. The 
MIC's for both trimethoprim resistant staphylococci and E. coli 
clones containing the staphylococcal gene were equal to those of 
transformants containing the =E�.--�c�o=l=i DHFR genes (MIC > 
lOOOug/ml). Likewise, the specific activities of the enzymes 
produced by the various transformants were very similar. 
However, the staphylococcal enzyme was four times less resistant 
to inhibition by trimethoprim(measured as the Ic50J than E. coli 
DHFR type I and 450 times less resistant than type II. These 
results suggested that while the trimethoprim-resistance gene 
product is a DHFR-like protein and over-production of it may be 
the cause of resistance, the enzyme is different than those found 
in E. coli. 
This conclusion was further supported by the results of in 
situ filter hybridization experiments. The 1.2 Kb EcoRI-Bglii 
fragment inserted into pOP203(A2+J was used as a probe. Target 
DNA included EcoRI digests of plasmids containing the 
staphylococcal trimethoprim resistance gene, plasmids encoding � 
coli DHFR type I and type II, and a cloned B. subtilis DHFR gene. 
No homology was seen with the E. coli or B. subtilis genes. The 
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trimethoprim resistance gene in staphylococci is not likely, 
therefore, to be closely related to those from these species. 
Bioassays of the level of trimethoprim in cultures showed 
no change after incubations of various lengths of time. This 
was true of both staphylococcal and E. coli strains harboring the 
' resistance determinant. That there was no change in the 
concentration of trimethoprim in the cultures shows that 
destruction of the drug was not occuring and further supports an 
altered target enzyme as the mechanism of resistance. 
Positive hybridization signals were seen between the pG020 
clone(the region downstream of the structural gene) and several 
EcoRI restriction fragments of pGOl and pGOS, suggesting the 
presence of a repeated sequence. These areas of homology 
coincided with areas of pGOl and pGOS known to be involved in 
deletions and transposon insertions. The pG020 probe also gave 
positive hybridization signals with restriction digest fragments 
of a variety of plasmids similar to pGOl and pGOS, but which do 
not encode resistance to trimethoprim and which did not hybridize 
with pG018(the structural gene probe). This repeated sequence may 
represent an insertion sequence that mediates rearrangements such 
as those responsible for the differences between pGOl and pGOS. 
The origin of this sequence is, of course, open to speculation, 
but if further characterization shows it to be a defective 
transposon or insertion sequence, 
this element as a genetic tool 
it may be possible to employ 
in the characterization of 
staphylococcal determinants by methods involving recombination or 
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insertional inactivation. 
IS elements are discrete, mobile genetic entities able to 
insert into new sites on the same or another replicon[24]. The 
repeated sequence cloned from pG01 appears at least five times on 
pG01 and at least four times on pGOS. It appears multiple times 
on a variety of other plasmids and in the chromosomes of some 
isolates. Most IS elements studied are between 0.7 and 1.8 
kilobases in size, though there is considerable variation. The 
cloned area of pG01 containing the repeated sequence is 0.7 
kilobases. Approximately 100 bases at the 5' end are part of the 
trimethoprim resistance gene. It is also possible that the 
repeated sequence extends beyond the Bglii site that marks the 3' 
end of the clone. 
All such elements sequenced share the structural feature of 
carrying inverted terminal repeats of about 10-40 base pairs. 
Alterations within these inverted repeats often affect 
transposition activity[39]. Therefore, it is possible that 
mutations in the nucleotide sequence could lead to a reduction in 
the efficiency with which an IS element transposes. The sequence 
of pG020(as well as the structural gene) remains to be 
determined. 
IS elements can mediate DNA rearrangements apart from 
transposition events[22]. IS elements also provide homologous DNA 
for general recombination systems. IS-mediated DNA 
rearrangements, together with rec-dependent recombination between 
IS elements and excission of the elements, may lead to gene 
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duplication and amplification. Also possible is the generation 
or decay of IS-flanked transposons, as well as other DNA 
restructuring. Deletions could be explained by a process in which 
an IS element transposed into a replicon that already carried a 
copy of the same IS element[35]. Depending upon the orientation 
of the transposed IS element relative to the preexisting copy, 
reciprocal homologous recombination would result in either 
inversion or deletion. IS-mediated deletions have been shown to 
remove one of the flanking repeats[13], resulting in an inability 
to further transpose. The efficiency of these recombinational 
processes depends on the length of the IS element, the presence 
of particular sequences on or near the IS element[25], and 
probably the spatial proximity of the two interacting elements. 
These kinds of IS mediated DNA rearrangements may also occur in 
rec independent cells[24]. Such IS-mediated rearrangements may 
help expand a prokaryotic organism's ability to adapt to new 
environments and provide a selective advantage to the population 
of organisms harboring mobile genetic elements. This process 
could explain construction of multiply resistant plasmids, such 
as pGOl and pGOS, and their lack of transposons. 
The association of IS elements carrying functional genes 
with transmissible plasmids facilitates the horizontal spread of 
bacterial genes to distantly related organisms. Microorganisms 
take advantage of these elements for adaptation to environmental 
conditions. Transposition of IS elements may occur more readily 
in resting cells(and probably under stress conditions) than in 
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exponentially growing cells[25]. Controlled conditions in the 
laboratory probably limit the number of IS-mediated 
rearrangements likely to be observed to much less than their 
actual frequency in nature. The low transformation frequencies 
generally obtained with staphylococci may preclude observing 
transposition events that occur rarely. 
pWG53, the trimethoprim resistance plasmid isolated in 
Australia, also encodes resistance to quaternary-ammonium and 
ethidium bromide compounds at a determinant which maps close to 
the trimethoprim resistance gene. This is similar to pGOl and 
pGOS and further suggests a common ancestry for these 
determinants and the plasmids harboring them. Plasmid pWG53 also 
contains a transposon encoding resistance to gentamicin. This 
gentamicin 
on pGOl, 
resistance gene is homologous to the resistance gene 
pGOS, and plasmids related to them. In the American 
isolates gentamicin 
transposability, or 
resistance 
lack thereof, 
is not transposable. The 
of the gentamicin resistance 
determinant may be another example of IS-like elements mediating 
intramolecular rearrangements. Determination of the nucleotide 
sequence of pG020 will be required to further investigate this 
phenomenon. 
Characterization of the trimethoprim resistance determinant 
and its evolutionary history continue. Three areas of further 
study will be pursued in the immediate future. The most 
enlightening of these likely will be nucleotide sequencing of the 
gene and the putative insertion sequence(s) nearby. This should 
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yield information as to regulatory regions and functional or 
defective genes. Recombinational experiments will help to 
determine if intramolecular recombinations are in fact mediated 
by the repeated sequence seen on pGOl and pGOS, and if these 
rearrangements occur in rec deficient hosts. Purification of 
the gene product will tell more about the mechanism of 
resistance, as well as lead to further experiments to 
characterize the gene and its background. Purified DHFR can be 
injected into rabbits for the purpose of obtaining antibodies to 
the protein. These can then be used to examine the antigenic 
relationship of this DHFR to other known DHFRs. 
Plasmid-encoded trimethoprim resistance has not been 
previously described among staphylococcal isolates in this 
country and has only recently been reported in Australia[45]. 
That these plasmids are conjugative implies that resistance to 
trimethoprim is likely to spread, particularly in those hospitals 
where these plasmids have been identified. Definition of a new 
mechanism of antibiotic resistance may suggest new modes of 
clinical treatment to avoid development of new resistant strains 
and the spread of existing ones, as well as expand our knowledge 
of resistance 
interest is 
in virulent pathogenic bacteria. 
how new resistance genes arise 
Of particular 
and how the 
determinants encoding them move among replicons. Insertion 
sequence-like elements have not previously been reported in 
staphylococci, but may play a role in the development of 
multiply-resistant plasmids. 
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